Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Goodwill (2018 - 2025)

Summit Therapeutics' Goodwill history spans 8 years, with the latest figure at $2.0 million for Q3 2025.

  • For Q3 2025, Goodwill changed 0.4% year-over-year to $2.0 million; the TTM value through Sep 2025 reached $2.0 million, changed 0.4%, while the annual FY2024 figure was $1.9 million, 1.53% down from the prior year.
  • Goodwill reached $2.0 million in Q3 2025 per SMMT's latest filing, down from $2.0 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $2.1 million in Q2 2021 to a low of $1.7 million in Q3 2022.
  • Average Goodwill over 5 years is $1.9 million, with a median of $1.9 million recorded in 2023.
  • Peak YoY movement for Goodwill: soared 614.25% in 2021, then fell 17.25% in 2022.
  • A 5-year view of Goodwill shows it stood at $2.0 million in 2021, then decreased by 10.5% to $1.8 million in 2022, then increased by 5.28% to $1.9 million in 2023, then fell by 1.53% to $1.9 million in 2024, then increased by 7.24% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for SMMT's Goodwill are $2.0 million (Q3 2025), $2.0 million (Q2 2025), and $1.9 million (Q1 2025).